The Walgreens are in line at Goldman Sachs to investigate the UK Boots chain

The Walgreens Boots Alliance is advising consultants to explore options for the sale of footwear, five years after the full ownership of the UK pharmaceutical companies.

Goldman Sachs will be asked to look into what happened to the Boots chain, founded in Nottingham by the Methodist family in 1849, either through trade or separate lists.

Secret groups have been the UK’s biggest buyer of the year this year, with TDR Capital participating in the Asda store in February and Clayton, Dubilier and Rice battling a competition from SoftBank-backed Fortress to take over Wm Morrison, another retailer, in October.

Boots was a UK-based company until 2007, when it was secretly acquired by Italian medical officer Stefano Pessina and the KKR finance group, which at the time was the largest in the UK.

Walgreens acquired the company two shares, to end the process in 2016, with Pessina being the senior member of the developed team.

Earlier this year Walgreens was elected Roz Brewer as an elder, while Pessina became chairman. Brewer has shown great interest in US hospitals and the team has already done so sold his distribution business at Amerisource Bergen.

Walgreens from Chicago said it was “right” to “announce new developments that need to be made as well as smart strategies. [in] October, which also includes a greater interest in North America and health care ”.

But he added that he “did not comment on market sentiment” and that Boats were “an important part of the community”.

Sky News first reported that Goldman was put on the line.

Some retailers are skeptical of the relationship between Boots and their US counterpart, because stores are numerous on different continents and do not have the same mix of products.

Critics have also claimed that Boats have lost their unique identity under US ownership and ownership, while its stores are becoming more and more understaffed.

Neil Saunders at GlobalData said the inclusion of Walgreens “did little good” and that it “suffered from a lack of funding and a strong focus on places like stores and jobs”.

“Walgreens lowered the shoe to its level, which was a bad result.”

But Boots has one of the UK’s leading commercials with over 14m members and a self-defense business that delivers more than 2,000 drugs each week instead of healthcare in the UK.

Sebastian James, director of Boots since 2018, has launched the program closing about 200 additional stores, increased its online offerings and invested heavily beautiful new-style houses was designed to take over small departments.

Boats also suffered during the UK closure of Covid, with many pharmacies still open to offer medicines but with sales – usually about three-fifths of sales – declining.

In August 2020, it lost £ 245m against a profit of £ 198m last year. Also, the landlords found it rude to discuss the lease again.